Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

BMI Thresholds of High Level Insulin Resistance in Adults with Normoglycemia According to Ethnicity

ENDO 2026

Chicago, IL, June 13-16,  2026

Poster presentation: BMI Thresholds of High Level Insulin Resistance in Adults with Normoglycemia According to Ethnicity

Authors: Louie JZ, Meigs JB, Melander O,  Shiffman D,  McPhaul MJ

Medical Specialty: Endocrinology, Cardiology, Cardiovascular disease

Related content

Publication
Insulin Resistance is Associated with Incident Prediabetes and Type 2 Diabetes in Normoglycemic Individuals
Audio Podcast
Action From Insight: Tackling Insulin Resistance
Audio Podcast
The Insulin Resistance Revolution: The Key to Preventing Chronic Conditions
Audio Podcast
Instant Insight: Metabolic Risk Panel
Publication
Fasting Intact Insulin by Mass Spectrometry Is Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease in Youth

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.